<- Go Home

Biopsys Medical, Inc.

As of July 31, 1997, Biopsys Medical, Inc. was acquired by Johnson & Johnson. Biopsys Medical, Inc. was engaged in the design, development, manufacture, and marketing of products for the diagnosis and management of breast cancer. The company's principal product, the Mammotome Biopsy System, was a less-invasive alternative to open surgical biopsy.

Market Cap

$268.9M

Volume

83.2K

Cash and Equivalents

$6.5M

EBITDA

-$1.8M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$6.6M

Profit Margin

56.60%

52 Week High

$34.75

52 Week Low

$13.00

Dividend

N/A

Price / Book Value

6.66

Price / Earnings

-911.76

Price / Tangible Book Value

6.66

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$2.1M

Return on Equity

N/A

Return on Assets

N/A

Cash and Short Term Investments

$21.8M

Debt

N/A

Equity

$40.3M

Revenue

$11.7M

Unlevered FCF

N/A

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches